Trials / Completed
CompletedNCT02929095
The Effect of Remifentanil-dexmedetomidine Compared With Remifentanil-midazolam on Patient's Satisfaction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- Male
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
Percutaneous trans-arterial angioplasty(PTA) is one of the peripheral arterial occlusive disease(PAOD) treatment. During and after PTA, ischemia-reperfusion pain is induced so proper analgesia is important. ischemia-reperfusion injury is due to reactive oxygen species. Dexmedetomidine has analgesic, sedative and anti oxidant effect. So the investigators research the patient's satisfaction that are given the dexmedetomidine during PTA procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexmedetomidine | |
| DRUG | midazolam | |
| DRUG | remifentanil | \- remifentanil will be administered to both dexmedetomidine and midazolam group as a routine part of procedure and it is no of interest of the protocol |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-04-02
- Completion
- 2018-04-02
- First posted
- 2016-10-10
- Last updated
- 2019-01-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02929095. Inclusion in this directory is not an endorsement.